Mabion
Mabion S.A., a prominent biopharmaceutical company headquartered in Poland, is at the forefront of developing innovative therapies in the biotechnology sector. Founded in 2007, Mabion has made significant strides in the production of monoclonal antibodies, focusing on biosimilars that enhance patient care and accessibility. With a strong operational presence in Europe, Mabion's core offerings include advanced biosimilar products that are distinguished by their high quality and cost-effectiveness. The company has achieved notable milestones, including successful collaborations and regulatory approvals, solidifying its position in the competitive biopharmaceutical landscape. Mabion continues to drive advancements in healthcare, committed to delivering unique solutions that meet the evolving needs of patients and healthcare providers alike.
DitchCarbon Score
How does Mabion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mabion's score of 4 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mabion's reported carbon emissions
In 2023, Mabion reported total carbon emissions of approximately 3,269,750 kg CO2e. This figure includes emissions from Scope 1, Scope 2, and Scope 3 sources. Specifically, Scope 1 emissions were about 368,980 kg CO2e, primarily from stationary combustion and mobile combustion activities. Scope 2 emissions accounted for approximately 3,269,750 kg CO2e, with the majority stemming from purchased electricity. Scope 3 emissions totalled around 3,315,310 kg CO2e, with significant contributions from upstream transportation and distribution, as well as employee commuting. In 2022, Mabion's total emissions were approximately 3,511,790 kg CO2e, indicating a reduction in emissions in 2023. The company has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or any formal climate pledges. However, the ongoing monitoring of emissions across all scopes reflects a commitment to understanding and managing their carbon footprint. Mabion's headquarters is located in Poland (PL), and their emissions data highlights the importance of addressing both direct and indirect emissions in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 660,930 | 000,000 |
| Scope 2 | 2,433,760 | 0,000,000 |
| Scope 3 | 417,100 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mabion is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
